EASL Liver Cancer Summit
EASL Liver Cancer Summit was held digitally on 4th – 6th February 2021.
Congrex had the privilege of helping EASL in the organisation and management of the 2-day event. EASL aims to improve your knowledge on the clinical treatment of liver cancer.
The Digital Liver Cancer Summit 2021 provided the latest on basic, translational, and clinical data – including on hepatocellular carcinoma, cholangiocarcinoma, and rare primary liver cancers. The discussions had at EASL Liver Cancer Summit directly impact future clinical practice worldwide, because all the new data related to clinical trials will be presented to participants and discussed intensely.
The total number of digital delegates at the event reached almost 650.
